CD63 and cancer: These authors analysed the expression of three exosomal markers (CD9, CD81 and CD63) and found a higher mean concentration of CD63 exosomes and a lower one of CD9 and CD81 exosomes between cancer patients and healthy individuals, although significant statistical differences were only observed with respect to CD81 exosomes [50].